Please assess the completion status of the following clinical trial:

Trial Title: Regional Analgesia After Cesarean Section

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* obtained consent~* singleton pregnancy~* subarachnoid anaesthesia~Exclusion Criteria:~* coagulopathy~* allergy to morphine and local anesthetics~* depression, antidepressant drugs treatment~* epilepsy~* usage of painkiller before surgery~* addiction to alcohol or recreational drugs

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- PCA (Type: EXPERIMENTAL): Subarchnoid anesthesia with bupivacaine PCA with morphine in the PACU
- TAP (Type: EXPERIMENTAL): Subarchnoid anesthesia with bupivacaine TAP (transversus abdominis plane block) ultrasound-guided regional block between abdominal wall muscles to treat acute postoperative pain. Stimuplex Ultra 360 needle will be used and 0.375 % ropivacaine administered (0.2 mL/kg) at the and of cesarean section.~PCA with morphine in the PACU
- QLB (Type: EXPERIMENTAL): Subarchnoid anesthesia with bupivacaine QLB (quadratus lumborum block) ultrasound-guided regional block between abdominal wall muscles to treat acute postoperative pain. Stimuplex Ultra 360 needle will be used and 0.375 % ropivacaine administered (0.2 mL/kg) at the and of cesarean section.~PCA with morphine in the PACU

Based on this trial design, predict the completion outcome and termination type (if applicable).